- A Phase I Study of CNF2024 Alone in Patients with HER2-Negative Advanced Breast Cancer or with Trastuzumab in Patients with HER2-Positive Advanced Breast Cancer
Modi, Shanu, MD
[Protocol 07-123]
- A Phase I Study of HER2/neu DNA Immunization for Patients with Metastatic or High-Risk Breast Cancer
Gilewski, Teresa, MD
[Protocol 04-101]
- A Phase I-II Study of Dasatinib plus Paclitaxel in Patients with Metastatic Breast Cancer
Fornier, Monica, MD
[Protocol 08-122]
- A Phase I/II Study of BMS-753493 in Patients with Advanced Cancer
Konner, Jason, MD
[Protocol 08-032]
- A Phase II Study Evaluating IPI-504 Plus Trastuzumab in Patients with Pretreated Locally Advanced or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
Modi, Shanu, MD
[Protocol 09-033]
- A Phase II Study of AZD0530 in Hormone-Receptor-Negative Metastatic Breast Cancer or Unresectable Locally Advanced Breast Cancer
Hudis, Clifford, MD
[Protocol 07-112]
- A Phase II Study of Bicalutamide for the Treatment of Androgen-Receptor-Positive, Estrogen- and Progesterone-Receptor-Negative Metastatic Breast Cancer
Hudis, Clifford, MD
[Protocol 07-022]
- A Phase II Study of Ertumaxomab in Patients with HER-2-Positive Metastatic Breast Cancer Progressing After Trastuzumab Treatment
Modi, Shanu, MD
[Protocol 07-155]
- A Phase II Trial of Patupilone in Patients with Brain Metastases from Breast Cancer
Seidman, Andrew, MD
[Protocol 07-036]
- A Phase III Study of Conventional Whole Breast Irradiation Versus Partial Breast Irradiation for Women with Early-Stage Breast Cancer
McCormick, Beryl, MD
[Protocol 05-068]
- A Phase III Study of Fulvestrant with or without Lapatinib (Tykerb®) for Postmenopausal Women with Hormone-Receptor-Positive Advanced Breast Cancer
Lake, Diana, MD
[Protocol 07-122]
- A Phase III Trial of Cyclophosphamide and Doxorubicin Versus Paclitaxel as Adjuvant Therapy for Women with Node-Negative Breast Cancer
Lake, Diana, MD
[Protocol 04-042]
- A Phase III Trial of Hormonal Therapy Alone or with Bevacizumab in Women with Locally Advanced or Metastatic Hormone-Receptor-Positive Breast Cancer
Dickler, Maura, MD
[Protocol 08-094]
- A Phase III Trial of Paclitaxel versus Nanoparticle Albumin-Bound Paclitaxel or Ixabepilone plus Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer
Lake, Diana, MD
[Protocol 09-100]
- A Phase IIb Study of Gemcitabine with or without Sorafenib in Women with Locally Advanced or Metastatic Breast Cancer That Has Progressed During or After Bevacizumab Therapy
Hudis, Clifford, MD
[Protocol 07-131]
- A Phase Ib Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer Who Previously Received Trastuzumab
Modi, Shanu, MD
[Protocol 09-093]
- A Phase Ib/IIa Study of AV-951 in Combination with Paclitaxel in Patients with Advanced or Metastatic Breast Cancer
Dickler, Maura, MD
[Protocol 08-136]
- A Prospective Analysis of Surgery in Patients Presenting with Stage IV Breast Cancer
King, Tari, MD
[Protocol 09-056]
- A Prospective, Longitudinal Study to Examine Time-Dependent Neurocognitive Changes in Patients with Breast Cancer Receiving Adjuvant Chemotherapy
Ahles, Tim, PhD
[Protocol 07-130]
- A Study Assessing the Use of AlloDerm in Two-Stage, Tissue Expander/Implant Breast Reconstruction
Disa, Joseph, MD
[Protocol 08-024]
- Acupuncture for the Treatment of Chronic Lymphedema
Cassileth, Barrie, PhD
[Protocol 09-136]
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
Dang, Chau, MD
[Protocol 08-017]
- BRCA1 Haploinsufficiency and Gene Expression
King, Tari, MD
[Protocol 04-045]
- Chemotherapy Decisions and Outcomes in Women Age 65 or Older with Operable, Newly Diagnosed Breast Cancer
Lake, Diana, MD
[Protocol 04-030]
- Chemotherapy-Induced Changes in Cognition and DNA in Breast Cancer Survivors
Ahles, Tim, PhD
[Protocol 07-090]
- Clinical Outcomes in Hereditary Cancer
Robson, Mark, MD
[Protocol 06-004]
- Clinical Significance of Germline BRCA Mutations
Offit, Kenneth, MD
[Protocol 96-051]
- Clinical Study of McGhan Corporation-Style 410 Silicone-Filled Breast Implants
Disa, Joseph, MD
[Protocol 06-024]
- Contrast-Enhanced Breast MRI Evaluation of Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer
Morris, Elizabeth, MD
[Protocol 03-019]
- Decision Making Regarding Prophylactic Mastectomy and Oophorectomy in Women Seeking Genetic Testing for Inherited BRCA1 and BRCA2 Mutations
Hurley, Karen, PhD
[Protocol 03-001]
- Evaluating the Causes of Cancer in Young Patients
Stadler, Zsofia, MD
[Protocol 09-068]
- Immunization of High-Risk Breast Cancer Patients with a Sialyl Lewisa-Keyhole Limpet Hemocyanin Conjugate plus the Immunological Adjuvant QS-21
Gilewski, Teresa, MD
[Protocol 06-156]
- Inamed Corporation-Style 410 Silicone-Filled Breast Implant Continued Assess Reconstruction/Revision Expansion (CARE) Clinical Study
Cordeiro, Peter, MD
[Protocol 06-076]
- Measuring Patient Expectations for Breast Reconstruction
Pusic, Andrea, MD, MHS
[Protocol 07-024]
- Measuring Patient Satisfaction in Breast Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
Pusic, Andrea, MD, MHS
[Protocol 05-058]
- Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
Chandarlapaty, Sarat, MD
[Protocol 06-163]
- Phase II Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients Age 65 and Older
Small, Trudy, MD
[Protocol 08-005]
- Phase II Study of a Novel Capecitabine Dosing Schedule in Combination with Lapatinib in Patients with Trastuzumab-Refractory Metastatic Breast Cancer
Traina, Tiffany, MD
[Protocol 08-025]
- Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients
Roth, Andrew, MD
[Protocol 09-116]
- Quantification of Sensation Following Postmastectomy Breast Reconstruction
Mehrara, Babak, MD
[Protocol 06-047]
- Sensory Morbidity Following Breast Surgery
Pusic, Andrea, MD, MHS
[Protocol 08-009]
- Serum Estradiol Levels in Postmenopausal Women with Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
Castiel, Mercedes, MD
[Protocol 09-110]
- Use of Breast MRI and Biomarker Studies to Characterize Tumor Response in Patients Receiving Neoadjuvant Treatment for Locally Advanced Breast Cancer
Montgomery, Leslie, MD
[Protocol 02-086]
|
